-+ 0.00%
-+ 0.00%
-+ 0.00%

INFLARX: SUBSEQUENT POST-HOC ANALYSES SUGGEST POSITIVE TREND IN FAVOR OF VILOBELIMAB, WITH SIGNALS INDICATING POTENTIALLY CONSISTENT TREATMENT EFFECT

Reuters·12/30/2025 12:30:01

Please log in to view news